WAM
INFI

Weiss Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Weiss Asset Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-13,101
Closed -$36K – 498
2018
Q3 		$36K Buy
+13,101
New +$27.1K ﹤0.01% 191

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Weiss Asset Management's INFI Position: Q4 2018 in Review

Weiss Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2018, closing a stake of 13,101 shares — an estimated $36K sold.

Weiss Asset Management first reported a position in INFI in Q3 2018 and held it in 1 quarter. The position peaked at $36K in Q3 2018. 64 funds tracked by Wall St. Rank hold INFI as of Q4 2018.

  • Weiss Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Weiss Asset Management sold 13,101 Infinity Pharmaceuticals, Inc. shares in Q4 2018, an estimated $36K.
  • Weiss Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2018 and held it in 1 quarter.
  • Weiss Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $36K in Q3 2018.
  • 64 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2018.

Based on Weiss Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.